46.50 (-%)
As of Nov 21, 2024
Source:
Janux Therapeutics, Inc is n innovative clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Our proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers and Tumor Activated Immunomodulators.
| Country | United States |
| Headquarters | san diego, california |
| Phone Number | (858) 751-4493 |
| Industry | manufacturing |
| CEO | David Campbell |
| Website | www.januxrx.com |